Clinical and Developmental Immunology · 2012 · 20 citations · 23 references
MedicineOncologyPathologyGene ExpressionMolecular OncologyOncogenesCancer BiomarkersLung CancerPleural MalignanciesBeta-catenin RegulationClinical Significance AssessmentLung Cancer PathologyMolecular Diagnostic MarkersMolecular Prognostic MarkersPleural Effusion AnalysisPleural Tumor BiomarkersPleural Tumor Molecular Pathology
OBJECTIVE: To evaluate diagnostic utility of Dishevelled-3 (DVL-3) mRNA and δ-catenin mRNA expression in pleural effusions of patients with lung cancer. METHODS: DVL-3 mRNA and δ-catenin mRNA levels were assessed by performing RT-PCR on pleural effusion specimens from patients with lung cancer (n = 75) and with lung benign disease (n = 51). RESULTS: The expressions of DVL-3 mRNA and δ-catenin mRNA were significantly higher in malignant than in benign lung disease (P < 0.01) and were obviously higher than cytology in adenocarcinoma (P < 0.01). In single use, DVL-3 mRNA had the highest specificity (94.1%) and PPV (95.7%), whereas δ-catenin mRNA had the highest sensitivity (92.0%) and NPV (88.5%). When combinations of markers were evaluated together, DVL-3 mRNA and δ-catenin mRNA gave a high-diagnostic performance: sensitivity of 100.0%, NPV of 100.0%, and accuracy of 96.0%, respectively. CONCLUSION: As molecular markers of detecting pleural micrometastasis, DVL-3 mRNA and δ-catenin mRNA are helpful to diagnose the cancer cells in pleural effusions of patients with lung cancer.
23
International Union Against Cancer. Classification of isolated tumor cells and micrometastasis.
P. Hermanek, R. V. P. Hutter, Leslie H. Sobin et al. · PubMed · 1999 · 550 citations
Classification of isolated tumor cells and micrometastasis
P. Hermanek, R. V. P. Hutter, Leslie H. Sobin et al. · Cancer · 1999 · 515 citations
Hadi Yaziji, Hector Battifora, Todd Barry et al. · Modern Pathology · 2006 · 190 citations · Full text